1

The European Network of Drug Services in Prison

FINAL TECHNICAL REPORT @ 03.06.2004

Cranstoun Drug Services

Agreement No. SPC.2002387 This report shows how Cranstoun Drug Services has successfully achieved the aims of the European Network of Drug Services in Prison (ENDSP) in the period 03.12.2002 to 03.06.2004. This report follows the previous interim reports of June 2003 and of December 2003. This report is structured according to the Description of Operation that appears as Annex 1 of our Agreement with the Commission. In each section information is given as to how Cranstoun’s performance has related with the activities included in our grant agreement with the European Commission for period to which the entire contract refers to, i.e., December 2002 - June 2004.

1) Ensure that the information distributed through the Network

reaches a wide and appropriate range of professionals in different disciplines and types of organisation, in order to enhance co-operation between the diverse organisations that are involved in providing drug and related services in prison.

Information has regularly been disseminated through the Network to over 6,000 professionals throughout Europe and beyond. These professionals include prison managers and officers, officials in penal administrations and state health authorities, staff and managers of non-governmental agencies that work on drug prevention and risk reduction, self-help organisations, academics and representatives of international organisations that work in this field. Information has also been disseminated through the Network’s lead contacts in each of the 15 member states, and in Poland, Slovenia and Czech Republic, as well as in the other CEECs. More specifically, best practice information and general information about ENDSP has also been disseminated during various international conferences and meetings by Edoardo Spacca (Project Coordinator), Steve Rossell (Chief Executive of Cranstoun Drug Services), Paddy Costall (Director of Services at Cranstoun and Project Manager), Kathryn Leafe (Director of Quality & Clinical Governance in Cranstoun), Anne D’Mello (Director of Services for Scotland), Laetitia Hennebel (ENDSP Research Officer), Vikky Bullock (ENDSP Officer), Jana Arsovska (Intern for ENDSP) and Grzegorz Krol & Magdalena Ruszkowska (Managers Central & Eastern ENDSP – Warsaw / NB: both of them participate to ENDSP activities, but their expenses are not included in this project as they are covered by the PHARE grant for Accession Countries).

2

Venues have included: - Conference “Arteterapia e Carcere – Applicazioni terapeutiche

per tossicodipendenti in Contesti trattamentali”, Italian Prison Administration, Rome, 4-5 December 2002;

- “Who’s guilty” Conference organised by the Action for Prisoners’ Families (London, 16 January 2003);

- Brussels, European Working Seminar on “User Groups within Prisons – An Untapped Resource?”, ENDSP, 13-15 February 2003;

- Ninth National Congress in Belgium on Drugs, organised by CIFop, Ville de Charleroi, DrugBeleid/Gestion des Drogues 2000 Charleroi, Belgium, 19-20 February 2003;

- 1st UK National Drug Treatment Conference, organised by The Methadone Alliance, London, 6-7 March 2003;

- Information Day on the Public Health Framework Programme, European Commission, Luxembourg, 21 March 2003;

- Partners in Prevention 2003 Conference, organised by Adfam London, UK, 25 March 2003;

- Community and Residential Services Conference on Client Choice: Reality, Rhetoric or Fantasy?, organised by Cranstoun Drug Services, Manchester, 7-9 April 2003;

- “Strengthening Partnership for a Safer Future”, 14th International Conference on the Reduction of Drug Related Harms, International Harm Reduction Association, ChiangMai, 6-10 April 2003;

- ‘Substitution treatment: Options, Protocols and guidelines’, training seminar organised by EATI, European Addiction Training Institute, in Porto, Portugal, 24-26 April 2003;

- European Seminar on the Reduction of negative health and social consequences of drug use in prison Conference organised by ENDSP, Rome, Italy 22-24 May 2003.

- Conference on Criminals Return into Society – Esperienze di Peer-Support in carcere e tra ex-detenuti, organized by ASL Milano, (ENDSP contact point for Italy), on 10-12 June 2003 in Milano

- Conference on Drug Demand Reduction Programmes, organised by the European Commission, DG Enlargement, in Budapest 12th – 15th June 2003;

- Annual Meeting of the European Network for HIV and Hepatitis Prevention in Prison, organised by WIAD, in Prague, on 11th –12th July 2003;

- Integration, Intervention & Innovation - 11th British Prison Drug Workers Conference, organized by Cranstoun Drug Services, in Nottingham, 23-25 July 2003;

- Pour une politique Europeenne en matiere de drogues: renforcer le partenariat institutions / societe civile, organized by the Green Group at the European Parliament, in Brussels, 17 September 2003;

- Dealing with Drug Use in Prison: Reviewing the European experience and sharing good practice - Conference on Drugs &

3

Infections Services in Prison, organized by the CEENDSP – Central & Eastern European Network of Drug Services in prison – Cranstoun Drug Services, in Popowo (Warsaw), 18-20 September 2003;

- 6th Colloque THS – Toxicomanie Hepatites Sida, organized by THS, in Aix-en-Provence, 6-10 October 2003;

- Annual meeting of the WHO-Health in Prison Project, organised by WHO and the Russian Ministry of Justice, Moscow, 23-24 October 2003;

- International Conference on the “Place of Civic Organisations in Counteraction Drug Abuse and Homelessness in the United Europe”, organised by MONAR Association, Warsaw, 24th – 26th October 2003;

- 9th European AIDS Conference, organised by the European AIDS Clinical Society, in Warsaw, 25th – 29th October 2003;

- 2003 International Drug Users’ Day, organized by Brugenforeningen – Danish Drug User Union, in Copenhagen, 31 October – 1 November 2003;

- Is the system still cracked? Conference on Crack Cocaine, organized by Cranstoun Drug Services & COCA, in Oxford, 3-4 November 2003;

- Mind the Gap – SPS Inclusion Conference, organized by the Scottish Prison Service, in Glasgow, 13-14 November 2003

- Biannual National Conference of the Finnish Prison Service, organized by the Finnish Prison Service, in Helsinki, 19-20 November 2003;

- Conference on HIV prevention in prison, organised by the UNDP Bielarus, Minsk, 27th - 28th November 2003

- Persistent Prisons conference, organized by the Open University, Milton Keynes, UK, 12th – 13th December 2003

- 7th European Conference on Drugs & HIV/AIDS Services in Prison, organized by ENDSP, Prague, 25-27 March 2004;

- Minimising the harm, maximizing theimpact, 15th International Conference on the Reduction of Drug Related Harms, International Harm Reduction Association, Melbourne, 6-10 April 2003

- Penal & Prison Services, organized by Milan Health Authority (ASL), Milan, Italy, 13 May 2004;

- 3rd UK Community & Residential Services Conference, organized by Cranstoun Drug Services, Glasgow, 17-19 May 2004;

- Vanguard 2004 – Reducing Drugs Related Harms and HIV/AIDS, organized by the Youth Forum for South East Europe, Belgrade, 20-21 May 2004;

- Biannual National Conference of the Polish Prison Health Service, Sucha, Poland, 1-3 June 2004;

Further to Conferences, visits to and from professionals in foreign countries have also been made and hosted:

4

2002-2003 Edoardo Spacca met in Rome on the 13th December Giulio Starnini, of the Health Services at the Italian Prison Administration’s Headquarters. They discussed cooperation between ENDSP and the Italian Administration, in particular with reference to the Rome Conference and, more in general, to the activities of the network. Kathryn Leafe, Director of Quality and Clinical Governance in Cranstoun Drug Services, went to the Czech Republic to train and assist our Czech Partner Sdruzeni Podane Ruce, in Brno, on the 6-10 January 2003, during the implementation of a project on drug awareness amongst professional from the public sector, including criminal justice ones; Dave Heywood and Saul Freeman (Service Managers from Cranstoun Drug Services) went to Varna, Bulgaria, (22 January – 2 February 2003), to assist our partners Better Mental Health Foundation in the implementation of a PHARE grant to set-up a structured day center, first ever (drug-free) service for drug users in Varna. Cooperation with them has increased in terms of activities and we wish to continue it. On the 15th January 2003, Paddy Costall and Edoardo Spacca met in Warsaw Gen. Jan Pyrcak, Director General of the Polish Prison Service, to confirm ongoing partnership. The Prison Service hosts the premises of the coordination office of the “twin” project to ENDSP, the Central and Eastern European network of Drug Services in prison – CEENDSP, funded under the PHARE Program and involving all 10 Accession Countries from CEE (please, see point 4). Edoardo Spacca and Laetitia Hennebel, met in London on 24/01/2003 Lars Moeller, WHO-Europe, coordinator of the Health in Prison Project, and Paul Hayton, from the WHO Collaborating Centre on Health in Prisons (UK Department of Health). Cooperation between WHO and the Network was planned for the next 18 months, with the involvement of WHO in ENDSP Steering Group, and with the participation of ENDSP to the HiPP Task Force, which will meet in Moscow for the first time in October 2003. Paddy Costall and Edoardo Spacca met in London Harry Fletcher, Sectretary General of the NAPO – National Association of Probation Officers, on the 20th February 2003, to discuss involvement of NAPO into the work of the Network in Central and Easter Europe, and in particular within the current policy developments in Poland concerning the establishment of the Polish Probation Service. A study visit from Czech Republic, coordinated with Sdruzeni Podane Ruce, was hosted on 14-17 April 2003 in London. Participants included members of the Probation Service and the Ministry of Justice. They were familiarised with the English system, both through presentations and on-site visits to a number of services in London metropolitan area.

5

Lynn Browner (Service Manager at Cranstoun) and Madaleine Rudolph (Project Worker at Cranstoun) went to Brno, Czech Republic, on the 27-30 May 2003 to train professionals (from the same fields as the participants to the previous study visit) on Prison Drug Prevention and Treatment models. Paddy Costall, Steve Rossell and Vikky Bullock visited the Czech republic on the 23-27th of June. They went to Brno, to carry out training for the partner organisation Sdruzeni Podane Ruce, and they met in Prague Pavel Bem, mayor of the City, and Kamila Meclova, Director General of the Czech Prison Service, to discuss the details of the Prague Conference, as well as to provide support & advice to the Czech prison drug strategy. Edoardo Spacca and Magdalena Ruskowska met on the 11th of July Mgr Kamila Meclova and Dr Bohuslav Burkiewicz, respectively Director General and first Deputy Director General of the Czech Prison Service in Prague, to discuss the PS involvement into the activities of the Network, and to further discussion on the PS participation to the Prague Conference. Edoardo Spacca met Parviz Afshar, Director of Health Care for the Iranian Prison Service, during his visit to UK, on 21-26 of July. During the visit it was discussed ways & forms of cooperation between the Iranian Prison Service & ENDSP. Vikky Bullock met Ms Ene Orumaa in London on the 8th of August 2003. Ms Orumaa is Project Co-ordinator for the National Programme for Alcohol and Drug Prevention in Estonia. She presented the activities of Cranstoun & the ENDSP to the visitor, who was in London within the frame of the Pompidou Group Fellowship, and she hosted a visit to two services managed by Cranstoun, “Oak Lodge”, TC in Putney, and “The Base”, Community Drug Agency in Wimbledon. Steve Rossell and Edoardo Spacca participated on the 19th of September to the Special Forum of the Director General of Prison Services from Central and Eastern Europe, held in Popowo, Poland, during the first Central and Eastern European Conference on Drug Services in Prison. Edoardo Spacca met Caren Weilandt, of WIAD, in Bonn on the 13th of October to discuss the future of the ENDSP, and the ENDIPP, the project that will take the relays from ENDSP in June 2004 (for more details, please see point 14). Paddy Costall and Edoardo Spacca met Natalia Kodakievich and Alexy Frolov, of AIDS Foundation East West in Moscow, on the 22nd of October, to plan the details of a training event commissioned by AFEW for the general directorate of the Russian Prison Service, which will be hosted in June 2004 in Scotland. Paddy Costall and Edoardo Spacca took part to the first meeting of the WHO-HiPP Task Force, which met in Moscow, on the 25th of October 2003. Cranstoun offered to WHO-HiPP to exploit synergies between work-

6

programmes of ENDSP, CEENDSP, the future Network (please, see point 14), and the work plan of WHO. It is worth noting that Cranstoun, along with AIDS Foundation East-West are the only two providers of drug services officially partners of the WHO-HiPP (please, see annex 15) Laetitia Hennebel and Edoardo Spacca met representative of the Finnish Prison Service, and visited the prisons of Vantaa and Hammelina on the 21st of November. On the 19th of November they met Marku Salminen, DG of the Finnish Prison Service to confirm partnership between the PS & ENDSP. 2004 Edoardo Spacca and Vikky Bullock met on the 22nd of January 2004 Lars Moeller, Alex Gatherer and Paul Hyton from the WHO-Health in Prison Project & the UK Cooperative Centre for the HiPP. They discussed future cooperation, Cranstoun involvement in the WHO task force for the HiPP, drafting of a common paper to be presented at the next HiPP annual meeting, as well as WHO-HiPP involvement in the Prague conference. Edoardo Spacca took part to the WHO-HiPP editorial meeting held in Zakopane, Poland, on 19-21 of February 2004 to discuss the feasibility of an international guide book on health promotion in prison. Jana Arsovska took part to the meeting of the European Drug Policy Forum in Paris on the 26 March 2004, to be informed on the plans of the European Forum on Urban Security of submitting a proposal to the European Commission about the creation of a Network of the Network. Edoardo Spacca took part to the meeting of the WHO-HiPP’s task force hosted by the Pompidou Group in Strasbourg on the 13 & 14 of May 2004. items discussed included the programme of the next WHO-HiPP annual conference (to be held in the Netherlands on October 2004), on the declaration on harm reduction that will be presented during that event, and on the guide for health promotion in prison initiated during the meeting in Zakopane earlier 2004. Paddy Costall & Peter Glass, Directors of Services in Cranstoun, took part to the International Conference on the Reduction of Drugs Related Harms in Melbourne, 20-24 April 2004 where they met Pat O’Hare & Gerry Stimson, former & current executive directors of the International harm Reduction Association, and Rob Phipps, from the Northern irish Health Service, to discuss ENDSP & Cranstoun involvement in the preparation and organisation of the 16th International harm Reduction Conference that will be held in Belfast in March 2005. the agreed that the ENDSP will take care and be in charge of the organisation of a number of sessions, including plenaries & debates, on the issue of drug use & drug users in prison. Between the 10-15 May 2004 Paddy Costall and Vikky Bullock hosted a study visit for Marek Szostek – Deputy Director of Polish Prison Service – responsible for Probation, Andrzej Martuszewicz - President of the Polish

7

Association of Probation Officers, and col. Adam Laptas - Regional Director of PS – Silesia. Please see Point 18 for more details. Edoardo Spacca, Vikky Bullock and Paddy Costall hosted a study visit for 4 professionals from Central and Eastern Europe between 24th and 28th May. The professionals invited were Dusan Valentincic, Director General of the Slovenian Prison Service, Olga Perhavc, Head of Drug Treatment at the Slovenian Prison Service, Laszlo Huszar, Deputy-Director General of the Hungarian Prison Service, Ruminta Stuykite, Director of the Central and Eastern European Harm Reduction Network, and Katarina Jiresova, Director of ODYSSEUS, Slovak NGO. Dr Perhavc had unfortunately to withdraw from the visit at the very last minute for the sudden loss of her mother. Please see Point 18 for more details. Peter O’Loughlin hosted a visit to Belmarsh Prison London for 8 members of the Iranian administration, including representative of the Drug Control Headquarters in Theran, on Wednesday 12th May. The visit took place in the context of a programme organised by the UK Home Office to familiarise the delegation with the way that the criminal justice system in England and Wales deals with drug related crime. Vitaly Melnikov, from the Russian New Drug Policy Alliance, was invited to the UK to speak at the 3rd UK Community and Residential Services Conference held in Glasgow from 17th – 19th May 2004, and to visit organisations involved in drug policy in England and Scotland. Organisations visited included the Scottish Drug Forum, in Glasgow, and community services in London managed by Cranstoun Drug Services (The Base, and Greenwich & Bexley). Paddy Costal, Vikky Bullock and Peter O’Loughlin on the 19th of March 2004 hosted an informal meeting in London with a high level delegation from Central Asian Countries as part of a study visit organised by the Foreign and Commonwealth Office on Prison & Prison Reform. Vikky Bullock attended a WHO HIPP project meeting hosted by the Ministry of Justice of the Netherlands in The Hague on 27th April 2004 to assist in the planning of the WHO HIPP Conference to be held in the Netherlands, October 21st-23rd 2004.

2) Continue to co-operate with the EMCDDA in gathering and

disseminating data throughout the project. Cooperation with the EMCDDA aims also to ensure that duplication of effort is avoided, and consistency within respective research agenda is guaranteed. ENDSP will focus its research activities on qualitative data, researching “what works” with drug dependence in prison in all EU Member States and in CEECs that have so far joined the network (see below).

Cooperation with the EMCDDA is now long-lasting and solid.

8

On the 2nd & 3rd of December 2002 (NB: in the final report this is wrong as the year reported was 2003) Edoardo Spacca participated in the EMCDDA Experts’ Meeting held in Lisbon on “Lessons Learned when Implementing Alternatives to Prison for Drug Dependent Offenders”, and Petra Paola Merino participated to the ENDSP Steering Group Meeting on the 12th of February 2003 in Brussels. Exchange of information and data are regular, and in May 2003 ENDSP participated in an EMCDDA tender procedure and was selected to provide data to the Centre through a pilot project of Data collection to develop an inventory of social and health policies, measures and actions concerning drug users in prisons. Edoardo Spacca and Laetitia Hennebel are those designated in the contract with the Monitoring Centre to coordinate and execute the project, and Ms Hennebel is the contact point with the EMCDDA. The award of the contract for this pilot to ENDSP also meant that cooperation become even more operational. The inventory is now being compiled, the data having already been gathered. The final aggregated tables will be ready for publication during summer 2004, and results published by the EMCCDA in cooperation with Cranstoun. Cranstoun was represented during the meeting of the working group on alternatives to imprisonment, held in Lisbon on 23-24 October 2003 on “Alternatives to imprisonment for drug users”, by Dr Uday Mukherji, non-executive director of CDS Finally, Petra Paula Merino took part to the conferences in Warsaw (September 2003), of which the Monitoring Centre was one of the supporting agencies. The EMCDDA has also been associated to the organisation of the Prague Conference, where the common EMCDDA & ENDSP project was presented to the ENDSP & CEENDSP partners during the Steering Groups on the 24th of March 2004.”

3) Transforming the role of the national Lead Contact Points of the

Network into that of National Coordinators for its activities, in particular for gathering and dissemination of research data. We have experienced in the past different levels of quality in the feedback received from Contact Points on various initiatives and we believe that, in order to allow the Network to accomplish the step forward in its scope of research activities, time has come to devote more resources to ensure that effective flow of data is established. Each National Coordinator will be asked to devote an average of two working days per month to the activities of ENDSP. We will also support the National Coordinators in further developing national Networks, in particular cooperating with them in the organisation of regional events.

9

Work has been ongoing for this target, in parallel with the implementation of the research project, and we achieved good results in making participation to the Network more intense. We have engaged research activities with most of the Contact Points, who are now providing data and carrying out national investigations (for those parts of the research specified in Point 12). The research project on Substitution Treatments in European Prisons was firstly presented them already last year, at the Special Forum for Lead Contact Points held in Vienna in October 2002, then it was again, and more comprehensively presented during the Steering Group meeting in Brussels in February 2003 (please, see Point 17). We experienced more involvement and participation to the Network activities through this increased role in the research project. Beside providing info on research, National Coordinators were in general more keen to be involved into the scientific organisation of the network’s events, as well as of their publication like Connections. Comments & advice from them was (and is) regularly being asked. Thanks to the Research Project on Substitution Treatments in European Prisons and the work with the EMCDDA we have also enlarged the ENDSP Coordinators’ constituency, and now have developed better contacts in a number of countries, like Spain, France, and Greece. As far as supporting the organisation of national events, we have negotiated and prepared our structured participation into 4 events, respectively organised by our Italian, French, and Finnish National Coordinators, and which took place in June, October and November 2003 and in May ’04 (Milan, twice, Aix en Provence, and Helsinki, please see point 1). Also network staff supported the organisation of other events, like the one organised by CEENDSP Polish National Coordinator in June 2004. On the top of the ENDSP work, and with the understanding that activities took place under a different budget from the one used in this project, it shall be noted that a whole team in Cranstoun has been in charge of relations with CEECs since the establishment of the Central and Eastern European branch of the Network. The vast majority of contact persons were also invited to a number of events during the project and Steering Groups meetings of both ENDSP & CEENDSP have always been held simultaneously during events such as the Brussels Seminar in Feb.’03 & the Prague Conference in Mar.’04. This crucially assisted networking amongst partners and increased their satisfaction in the Network, while also being an occasion for suggestions, feed-back and frank & constructive critics. Please, see also Points 5, 7, 13, and 17.

10

4) Establish new National Coordinators for Czech Rep., Estonia, Hungary, Norway, Iceland, Switzerland, Lithuania, Latvia, and Romania.

This target has become an ENDSP-Integrated project on its own, and the award of a subvention under the PHARE Drug Demand Reduction – Network Facility Programme has allowed the creation and establishment of the Central and Eastern European Network of Drug Services in Prison - CEENDSP. Thanks to this successful proposal presented last year in September to the European Commission and with the active support of the Polish Prison Service, we could open an office in Warsaw, within the premises of the regional headquarters of the Service itself. To implement the project, Cranstoun has employed two Polish managers, Grzegorz Krol and Magdalena Ruszkowska, who are in regular contact with partners from all the CEECs. Partners include several Prison Services, NGOs, and Governmental Agencies. Please, see Annex 1 (submitted with the 1st Interim Report @ 3rd of June 2003, for more detailed information on the CEENDSP, including list of partners, activities, research and events.

5) Organise the 2nd Special Forum for all the National Network Coordinators at the 7th European Conference in Prague (see below). The aim of this Forum is to gather their views and visions on the functioning of the European Network.

The second special forum for the National Network Coordinators meeting was held in Prague on 22nd March on the eve of the 7th annual conference of the European Network of Drug Services in Prisons. The CEENSP steering group meeting took place in parallel and a dinner was held to allow networking between the two groups of professionals. Attendees to the ENDSP Special Forum included:

- Jan Flikkema, Prison Service, NL; - Marketta Jungner & Kirsti Nieminen, Prison Service, Finland; - Carl Åke Farbring, Prison Service, SW; - Alfred Steinacher, Prison Service, AU; - Maria Grazia di Bello & Silvia Cocchi, Health Authority Florence, IT; - Dario Foa, Health Authority Milan, IT ; - Graciela Silvosa Rodriguez & Israel Pardo, Prison Service & Ministry of

Interior, SP; - Alette Reventlow, Prison & Probation Service, DK; - Vikky Bullock, Laetitia Hennebel, Edoardo Spacca, and Steve Rossell,

Cranstoun Drug Services; - Lars Moller, WHO-HiPP;

11

- Joris Casselman, Katholieke Universiteit Leuven, BE; - Heino Stöver, University of Bremen, GER; - Petra Paula Merino, EMCDDA; - Natacha Grenier, European Commission.

The last session of both ENDSP & CEENDSP meetings were held together and Caren Weilandt & Edoardo Spacca presented to the Forum the plans and projects of the new network that fusions together ENDSP, CEENDSP & the European Network for HIV & Hepatitis Prevention in Prison (please, see Point 14). Please see Annexe 23 for the minutes of the meeting.

6) Gather, edit and distribute information on the policies and

practice of agencies that provide drug and related services to prisoners throughout the EU, primarily through the publication in 5 languages (En, Fr, Ger, Sp, It) of a newsletter, “Connections”. At least 4000 copies of the 13th (May 2003), 14th (Oct. 2003) and 15th (May 2004) issue will be distributed.

In order to enlarge the dissemination of the newsletter, and to reduce publication costs with in mind the fact that Cranstoun manages also the CEENDSP project for Central & Eastern Europe, it had been decided to integrate the original Connections to the newsletter that is produced by the CEENDSP. The first common edition of the ENDSP & CEENDSP newsletter, initially scheduled for May 2003 in both Network’s work plans, was published with a delay of 4 months due to a number of events organised in the first six months of the year, in which ENDSP & CEENDSP Coordinators were involved (ENDSP conference in Rome 23-25 May 2003 and CEENDSP conference in Warsaw 18-20 September 2003). Also, the process of integration of both ENDSP and CEENDSP publications was longer than foreseen. The issue 13 of Connections, now common ENDSP & CEENDSP newsletter, contained 13 articles gathered from various sources and regarding research, policies and practices. It is published in 6 languages: English, French, German, Spanish, Italian and Russian. A total of 7,350 copies of issue No 13 have been printed (EN 4,300, FR 400, SP 250, IT 300, GER 1,100, RUS 1,000) The English-Russian versions of the first issue (Connections No13) have been translated and printed outside the ENDSP budget. Three copies of each linguistic version are attached as Annex 10. The second issue of Connections for the current work plan (14/2003), initially scheduled to be published in November 2003, was published in January 2004. It contained 13 articles. Three copies of each linguistic version are attached Annex 20. A total of 3050 copies were printed in London (EN 2000, FR 500, IT 300, SP 250). The German and Russian linguistic versions were

12

printed in Warsaw under the CEENDSP project, as well as the rest of the English copies (for a total of 7350). Issue 15 of Connections was published on the 1st of Jun. ‘04. 3 copies of each linguistic version are enclosed to this report as Annex 21. A total of 3050 copies were printed in London (EN 2000, FR 500, IT 300, SP 250). The German and Russian linguistic versions were printed in Warsaw under the CEENDSP project, as well as the rest of the English copies (for a total of 7350). Additionally, starting from issue 13/2003, the English version of the newsletter is distributed via Internet, in electronic format which refers directly to the articles published on the CEENDSP website www.ceendsp.net. This constitutes a very efficient and low-cost tool for ENDSP/CEENDSP website promotion and information flow.

7) Organise, in co-operation with Trimbos Insitute (NL), Sananim and

Podane Ruce (NGOs from CZ), the Czech Ministry of Justice, the EMCDDA, and the WHO, a 7th European Conference on Drug and related Services in Prison in Prague, April 2004. This Conference will, along with the other activities of the Network, enable to further exchange of knowledge and expertise on the prevention of drug dependence in prison, with specific reference to the reduction of demand for drugs, and the promotion of health (particularly the reduction of risks associated to the use of drugs) in prison. The event will be structured to include sessions on policy and practice. Particular attention will be given to organise an extensive exchange of information, knowledge and experiences on the findings of the ENDSP research project on substitution treatment in European prison systems (see below). Further, space will be given to organisations and services across Europe to present their projects and activities in an “expo” that will open one day before the formal business, and will continue throughout the conference. The Conference will be co-sponsored by WHO and EMCDDA. The event will be attended by approximately 300 participants. We will also co-operate with the PHARE programme and with the Pompidou Group to ensure that this Conference includes speakers and participants from a wide range of International organisations, prison administrations and prisons, statutory health authorities, universities and non-governmental organisations, particularly from CEECs.

This objective was met in all its targets. The event was held on 25th-27th March 2004 at Prague Congress Centre. Both the Czech Prison Service and the City of Prague have been involved, and their support was secured. Delegates were addressed by both the deputy Minister for justice with responsibility over Prisons and the Mayor of Prague, who also hosted a reception for the delegates at the City Hall.

13

Cranstoun Independent Management, a fully owned subsidiary of Cranstoun Drug Services, was subcontracted to organise the event, and to provide delegates’ data management & processing. Copy of the contract signed with CIM is annexed herewith Annex 24. 302 delegates came to the Prague conference, representing 46 countries and a total of 172 statutory & non-statutory, national & international organisations. The countries represented included all EU MSs and accession countries as well as the majority of Balkan states & NIS, including Central Asian Countries. Others were USA, Iran and Thailand. The event also celebretated 10 years of the activity of the European Network of Drug Services in Prison. Beside statutory Czech organisations others supporting the event were: the Austrian Ministry of Justice, the Open Society Institute, the EMCDDA, WHO-Europe, AIDS Foundation East-West (AFEW), Fundation Secretariado General Gitano, the European Network for the Target Group of Mobile Drug Users (ACCompany), and the European Network for the Prevention of HIV/AIDS and Hepatitis in Prison (ENPHHP). Czech NGOs partners of Cranstoun and CEENDSP were also involved in the event, and A.N.O. (the humbrella association of Czech’s NGOs providing drug services), Podane Ruce and SANANIM actively cooperated to the good outcome of the event. In terms of involvement of International Organisations, the Pompidou Group has been actively represented by Chris Luckett, secretary general, and Eva Koprolin, official in charge of prison Drugs matters. WHO-Europe co-chaired with ENDSP one of the main session of the event on substitution treatment, and, held a special meeting on the draft text of the consensus statement on harm Reduction in Prison, which will be discussed by governmental organisations during the next annual meeting of the Health in Prison Project, cosponsored also by Cranstoun & ENDSP, in October 2004. EMCDDA was also given space both at the ENDSP & CEENDSP Forum on the eve of the Conference, in order to promote the Inventory on Drugs in prison that next year will be extended to the CEECs. From other partner organisations it is significant mentioning AFEW that lead a delegation from Russia, including the deputy Director general of the Russian Prison Service, Dr Alexander Kononez, head of medical services of the GUIN. Toghether with the event also the Steering Groups of the ENDSP & CEENDSP were held on the eve of the Conference, and a special session of the SG gathered together all partners from Western & Eastern Europe to discuss the future plans of the network (its transformation into ENDIPP, please see below Point 14) which were presented jointly by Caren Weilandt, of WIAD, and Edoardo Spacca, of CDS. Organisation & Promotion of the Event

14

In terms of preparation to the event, Paddy Costall, Steve Rossell, Vikky Bullock (CDS), and Salma Master (Cranstoun Independent Management) went to Prague on the last week of June 2003, while Edoardo Spacca, Salma Master and Andreas Woreth (Director of Central Services in Cranstoun) went there on the 6-8 November 2003, to discuss details of organisation with conference venues and conference partners. Edoardo Spacca also met the heads of the Czech Prison Service during a meeting of the European Network for the Prevention of HIV/AIDS & Hepatitis in Prison, which was held in Prague in July 2003 (please, see point 1 of this report). The leaflet of the event was produced in 5,500 copies and disseminated in November 2003 (3 copies were presented with the 2nd interim report as Annex 12), both in electronic & hard copy version. On the morning of Thursday 25th visits to prisons in and around Prague took place, with the support of the Czech Prison Service. A list of participants, along with the conference reader & materials are enclosed with this report (Annex 19). Vikky Bullock, ENDSP Officer, has been coordinating a team of volunteer rapporteurs that have minuted the event. Please see the Conference Report, Annex 27. The report was published in May ’04 in 500 copies. Plenary sessions have benefited of simultaneous interpretation into English, Czech, Russian, French and German. Synopsis of the programme and Contents of the event: The programme of the event benefitted of contribution and suggestions from national Contact Points and it covered the following topics:

- minority groups; - substitution treatments; - different patters of substance misuse; - the role of prison staff in drug demand reduction; - epidemiology; - multiagency at work: the Scottish system; - users’ groups involvement; - provision of services in CEECs; - harm reduction & abstinence oriented treatments.

With five weeks to go before Enlargement, the issue of migrants opened the Conference through a plenary debate, where it was common belief that disappearing boarder restrictions as such should not cause an increase in the prison population. Moreover, delegates stressed that increased mobility could be seen as an advantage. The conference heard that the Austrian experience indicates that the population of foreign nationals in European prisons will not increase because a large number of them will now have the right to be of legal status, and will no longer be pushed into illegal circumstances, to find illegal work, and thereby run the risk of entering into the criminal justice system.

15

Nevertheless, many speakers pointed out that foreign nationals are often exposed to expressions of xenophobia. However, prisons are not creating the problems, but are merely reflecting problems that exist on the outside. Research showed that foreign nationals tend to get harsher punishments than domestic prisoners. Also, the criminal justice system and policing practices tend to focus on minority groups. There is a higher rate of criminality in particular groups, but also in groups of citizens of a country in certain social circumstances. We need to remember that prisons are part of the overall community. Such a broad variety of cultures in the EU requires more cooperation in order to address prisoner’s needs appropriately, providing health care and respecting individual principles, such as attitude toward drug users. In that context, the work of peers was emphasized in making the bridge between minority groups and the majority organizations. Thus, developing co-operation between the prison service and NGO’s is something that can help. Then, the two Friday plenary sessions focused on the research projects implemented within the ENDSP and the CEENDSP Networks: respectively the availability of substitution treatment in European prisons and the availability of drug services & healthcare in Central and Eastern European Prisons. Apart from the plenary debates, eight workshops were organised allowing participants to exchange opinions and experiences on particular issues relevant to them. In Eastern Europe the main drug issues centre on the increasing use of synthetics such as amphetamine and methamphetamine. Cocaine is still considered to be too expensive to become the most common drug of choice however there is clear evidence of its use. 'Substitution treatment was covered in depth on the second day of the conference through a plenary session as well as during 3 hour workshop, where 9 national experts from different countries gave feedback and comments on emerging issues and challenges for substitution treatment in prison. The workshop was co-chaired with WHO-Europe (Health in Prison Project) demonstrating the interest of key international bodies. The heterogeneity of the provision and availability between and within countries of such treatment was underlined, as well as the need to create some clear guidelines and protocols. The conference finished with an impassioned plenary debate: “Can harm reduction and drug free approaches co-exist and co-operate? The delegates stressed that there is no solution to the issue of problematic drug use, but that there are many options, some of which are dependent on attitudes and resources in the surrounding society and local situation (for instance, when in Sweden the majority of drug users are amphetamine users, there will be low pressure to implement needle exchange programmes). It was suggested that there is a need to elaborate one drug policy where harm reduction is a force element besides prevention, treatment and law enforcement. Delegates commented that harm reduction measures should be understood as reducing morbidity and mortality in those who, for the time being, cannot

16

stop drug-taking behavior, especially injecting. On the other hand, we should not stop providing drug free approaches, because not every drug user wants to continue using. In conclusion to the debate, one of the panellists stated that some programs can coexist and cooperate, others cannot or at least not yet, because we need time to learn from each other. This comment underlined the importance of the Network’s role in promoting exchange of existing evidence about effective projects and experiences that contribute to the well being of drug users and to the population at large in a public health perspective. The closing session of the 7th European conference saw the appointment of the first Paolo Pertica Fellowship, an initiative of Cranstoun Drug Services (outside the budget of this project) to celebrate the 10th anniversary of the Network (please see Annex 29, call for proposals of the PP Fellowship). The initiative intends to support the further development and expand the knowledge base regarding work with drug users in prison across Europe. The scholarship of 10,000 euro was awarded to Elena Grigoryeva from the Byelorussian NGO InterSocAid, for the implementation of a multi-country research study entitled Gender-Sensitivity of Existing Strategies and Activities on Re-socialization of HIV-positive Female Prisoners in 5 Newly Independent States (Belarus, Russia, Ukraine, Moldova, Armenia). The proposal came from the premise that in the region 96 percent of HIV positive women prisoners are women with a history of problematic drug use. The results of the research will be promoted within the Network and presented at the next European conference in Budapest (2nd Semester 2005).

8) Organise a Regional meeting at the 11th British Prison Drug Workers' Conference (York, July 2003). This project will support the participation in this national meeting of European experts in the field of drug demand and harm reduction in prison.

This target was achieved. The 11th British Prison Drug Workers Conference has been organised by Cranstoun, and took place in Nottingham the 23-25 of July 2003. More than 350 delegates attended from all over UK. A number of European and International speakers were invited, and presented practices and ideas from their countries. The following professionals were included in the official programme: Willy De Maere (Needle Exchange Coordinator for the Flemish Community, and ENDSP coordinator for Belgium), Jindra Voboril (Chief Executive of Sdruzeni Podane Ruce, Czech Republic), Alfred Stainacher (Governor of Hirtenberg Prison, Austria), Parviz Afshar (Director of Medical Services - Iranian Prison Administration), and Eddie Ellis (President of the Centre for Community Justice, New York).

17

The support of the European Commission was acknowledged in a number of ways, including on the conference materials (please, see enclosed Annex 13). The launch of last year’s ENDSP research study on services to families of drug using offenders was organised in the afternoon of the 24th July, with public acknowledgment of the EC support to the project. Additionally to the 11th British Prison Conference, ENDSP was involved also in the promotion of a 2 days Conference on Crack Cocaine, organised by Cranstoun in Oxford on the 3-4 November 2003. Ms Janine Wildshut, from Mainline, NL, was invited to present the views of her organisation around the issues of crack cocaine & the criminal justice system. Also in this case, the support of the EC to ENDSP was widely acknowledged on the Conference Materials (please, see Annex 16). As well as promoting the participation of representatives from other European member states to the Prison Drug Worker’s conference and the Crack Cocaine confrerence, this year ENDSP also ensured contributions from Job Joris Arnold, Director of MDHG, the Amsterdam’s Drug Users Union, and Vitaly Melnikov from the Russian New Drug Policy Alliance at the 3rd UK Residential and Community Services Conference in Glasgow, Scotland, 17th – 19th April. Also in this case, the support of the EC to ENDSP was widely acknowledged on the Conference Materials (please, see Annex 17). 9) Investigate the needs and begin to develop training modules for

professionals from CEECs working with drug dependence in prison.

This specific target has become part of a wider activity, i.e., the research project on the provision of services to drug users within prison in the 10 Accession Countries of CEE. The findings of this research project (due for publication in July 2003) will allow us to have a clearer picture of the needs for interventions with drug users within the Prison Systems of central and Eastern Europe. The organisation of Training Academies has been foreseen in the future work plan of the new Network created by WIAD & Cranstoun (please, see Point 14). Please, see above, Point 4 (and Annex 1 of the 1st Interim Report at the 3rd of June 2003 for this grant agreement) on the CEENDSP.

10) Organise a European seminar on best evaluated practices of harm reduction activities in prison. This event will take place in May 2003 in Rome. It will be attended by 80/100 participants.

The Rome Seminar took place on the 23 to 25 of May, in Rome at Four-Points Sheraton Hotel. It was attended by 152 participants, from 32 European countries, representing both statutory and non-statutory bodies. Delegates

18

arrived from all Accession Countries, as well as from the majority of EU Member States and from as far as Uzbekistan and Tajikistan. We have been able to engage both the Italian Prison Administration and the City of Rome in scientifically supporting the event, while AIDS Foundation East-West and Open Society Institute contributed towards attendance costs of quite a number of delegates, and gave comments and suggestions on the programme. A list of participants, along with the conference reader & materials are enclosed with this report (Annex 2 of the first interim report). Vikky Bullock, ENDSP Officer, has been coordinating a team of volunteer rapporteurs that have minuted the event. Please see the Seminar Report, Annex 26. The report was published in May ’04 in 500 copies. Plenary sessions have benefited of simultaneous interpretation into English, Italian and Spanish, which was at the end provided instead of German and based on participants and speakers linguistic composition. Contents of the event The title of the Seminar in itself aimed to embrace a large range of interventions, focusing on HIV and infections prevention practices within demand reduction strategies in the criminal justice system. The event was aimed and designed to be a forum for discussion and examination of examples of good practices in relation to the implementation of the principle of equivalence, including barriers, costs, benefits, and sustainability of interventions. These aims generated discussions on dilemmas, ethics and pragmatism and whether they can go hand in hand or instead are incompatible. A recurrent point of view during the event was that one size does not fit all, and that to carry forward the principle of equivalence, we must consider that everybody has equal rights to access the same standard of care and treatment services, wherever they are, and that services must be multidisciplinary, multi-agency and adapted to the local setting. It was stressed in presentations and discussions that the punishment is deprivation of liberty in itself, and should not be administered through day-to-day life in prison. There was also a strong focus on the definition of the term “harm reduction” as an acknowledgement of the reality of drug use in prison and its pragmatic and effective response, at least for part of the drug using population. This definition however cannot stand alone and it must be acknowledged that harm reduction in itself is not a satisfactory response, and there must always be diverse options, for those who wish to use prison as opportunity to begin drug free treatment.

19

Unfortunately, there is often a gap between theory and reality and many delegates and speakers pointed out how difficult is to forge a link between prisons and communities, and that it is rare to see the implementation of community interventions within the prison setting. Nonetheless, it was suggested that we weigh up the cost of interventions with the benefits for the individual and society, and actually communicate these arguments to both policy makers and general public in an attempt to facilitate policy development. Finally, a number of participants pointed out that a prison sentence should be avoided whenever dealing with drug users and that alternative sentencing is a far more cost effective exercise than penal institutions. The feedback we received from participants was very positive, and the comments made were included in the Seminar Report, which was published in May 2004 in 500 copies (Annex 26). Promotion and Organisation of the Seminar 5,500 copies of the leaflet (5 copies enclosed with this report, Annex 3 of the first interim report), including call for abstracts, were distributed in March 2003 throughout Europe and beyond, both directly through our database, and indirectly through our National Contact Points and Coordinators, and through the scientific partners of the event. Logistic arrangements were made already at the very beginning of the project, in December 2002. Edoardo Spacca, Vikky Bullock and Salma Master (Manager of Cranstoun Independent Management), visited venues and had preliminary meeting with Giulio Starnini, from the Italian Prison Administration on 11-13 December 2002. The network steering group meeting in February in Brussels also discussed the programme of the event. The conference operations and logistic were arranged through Cranstoun Independent Management, which was contracted to do so on 4th December 2002 (please, see Annex 4 of the first interim report, contract with Cranstoun Independent Management).

11) Establish a scientific steering committee with the task of

supervising and scientifically reviewing the ENDSP research project on substitution (see below). It will be composed by Dr Heino Stöver, from Bremen University, by Prof. Joris Casselman, from Katholieke Universiteit Leuven, by officials from WHO HiPP and EMCDDA, by ENDSP’s researcher and coordinator, and by 2 National Coordinators. The Committee will meet twice in London, at the beginning of the research, and after 9 months since then,

20

and once at the end of the research at the Prague Conference (see above).

The Scientific Advisory Group has been formed and held its meetings regularly, either in London or in Brussels, or during the events and meetings organised by ENDSP and CEENDSP. For more details on its scope of work and the meetings held, please see Point 12 below and Annex 5 of the first interim report.

12) Carry out a research project on “Substitution treatment in EU-

Member States Prisons: Practices, Problems, and Standards”. Drug using prisoners who were receiving treatment in the community prior to imprisonment are often, and in most countries, not able to continue with their treatment whilst in custody even in countries with an extensive prescribing policy and regime outside. In prison substitute prescribing is often limited to the provision of symptomatic treatment or short term methadone detoxification on admission. Provision of methadone treatment within prisons varies considerably across countries and it often depends on the prescribing policy of the doctor in charge, exercising their clinical judgement. Although there are several recommendations from international organisations (WHO 1993) and experts (ENDHASP/Oldenburg Conference 1998) to continue substitution treatment in prison, still a cessation of methadone maintenance treatment can be observed in nearly every EU MS. The study will cover 18 countries, the 15 MSs, plus POL, Slovenia and the Czech Republic. Its objectives are: a) inventory substitution practices in European prisons, related to the practices in the communities; b) analysing the reasons for cessation of methadone prescription; c) giving an overview of the national and regional development of health care standards with regard to substitution treatment; d) initialising an exchange of information of medical doctors and health care workers in charge of prison health care services; e) Identifying “Best Practice” for methadone prescription in prisons. The results of the study will be widely debated at the Prague Conference, and will be published in May 2004. Dr Heino Stöver will be engaged to coordinate and carry out the research project, with the full-time assistance of ENDSP “in house” researcher. Prof. Joris Casselman will be engaged to provide academic review of the research throughout the research project.

The research project was successfully implemented and research report printed in 900 copies has been produced (Annex 28). Synergies were developed between this study and the one on the 10 CEECs carried out under the CEENDSP project (please see above Point 4), and the team of researchers worked on the project right from the beginning of the

21

contract with the EC. Officials from WHO and EMCDDA were also kept informed on the development of the study, and HEUNI, the European Research Institute on Crime Prevention and Control affiliated with the UN, joined the research project by actively supporting its implementation.

Table of contents:

1. Introduction 2. Aim of the study 3. Research design 4. Research methodology 5. Cooperation with CEENDSP research 6. Scientific Advisory Group (SAG)

1. INTRODUCTION

Within the context of the activities of the ‘European Network on Drug Services in Prisons’ (ENDSP), Cranstoun Drug Services managed a research project on ‘Substitution Treatment in European Prisons’ (STEP) over a period of 18 months in 18 countries (the 15 EU countries, the Czech Republic, Slovenia and Poland – NB: for the last three countries no personnel fee is budgeted within this project, while synergies are exploited in the context of CEENDSP).

The researchers were Dr. Heino Stöver (University of Bremen, Germany) and Laetitia Hennebel (ENDSP/Cranstoun Drug Services, U.K.). The study was carried out with the active support of the ENDSP’s national contacts.

Professor Joris Casselman (Catholic University of Leuven, Belgium) was involved in the research as scientific peer-reviewer and Chair of the Scientific Advisory Group – SAG (see below).

The final report was printed end of May 2004 in 900 copies. The preliminary findings of the research were presented during the ‘7th European Conference on Drug & HIV/AIDS Services in Prisons’ organised by ENDSP in April 2004 in Prague.

2. AIM OF THE STUDY

The general aim of the research was to conduct an overview study of substitution treatments offered in prisons in 18 European countries.

The research had the following specific objectives: • Conduct a literature review on substitution treatment in prisons; • Elaborate an inventory of the substitution policy and practice in prisons; • Provide an overview of the national and regional developments of

health care standards with regard to substitution treatments in prisons; • Point out issues related to cessation and continuation of substitution

treatments prescription from the community into the prison setting; • Initiate the exchange of information from medical doctors and health

care workers in charge of prison health care services;

22

• Identify ‘Good Practices’ of substitution treatment prescription in prisons.

3. RESEARCH DESIGN

Within the first semester of the research (December 2002 to May 2003), the following results were reached:

1. The literature review was conducted on substitution treatment in prisons. Several databases and archives were accessed, such as the ENDSP’s ‘digest’, the ARCHIDO (University of Bremen) database, and so on. The database of references was completed during the following two semesters.

2. Distribution of work between the two researchers was organised in the early stage of the project: each researcher was in charge of 9 countries and conducted the qualitative field visits in these 9 countries from beginning 2003 to May 2004 (in May 2004 France was visited: the delay for this field visit was due to the late authorisation of the research by French administration).

3. National contacts in each country were identified and have been working on their tasks, i.e. to:

a. Collect large information on substitution treatment in their country (at the general/community level and at the prison level)1;

b. Facilitate the organisation of the field visit; c. Assist the researcher during their field visit; d. Provide availability and support for issues that may have arise

during the research; e. Provide comments on country report.

National contacts’ feedback has been extremely good, resulting in the involvement of one or two contact person in each of the 18 countries. Their tasks have been clearly formulated in a contract form and their involvement enriched the whole data collection, gathering general information on substitution and drug treatment in each country, as well as the practical side of the field visits.

4. Authorisation to conduct the research project in each country was requested. Only Luxembourg refused permission to conduct the study. In the UK field visits were conducted only in Scotland, for the English & Welsh Prison Service did not authorise the project.

5. The structure and methods for the qualitative study (two interview schedules to be used as a guide-questionnaire when interviewing prisoners and professionals) were elaborated at the beginning of the study. A pilot interview was carried out in April 2003, to test whether the methodology instruments were suitable, rigorous, relevant and

1 The way such data is collected (with or without colleagues) is up to each national contact.

Information must be as large, complete and appropriate as possible.

23

comprehensive to cover the whole range of topics on substitution treatment in prison. It resulted that the designed two instruments were suitable tool for the research.

6. Field visits: Each visit lasted for about 4 to 5 days, depending on the geographical location of the prisons and the agenda prepared by the national contact. The field visit extended to up to 7 days in some countries. During the field visits the researchers spoke with representatives of the Ministries of Justice and/or Health and NGO’s involved in prison work. Requirements for the field visit was to visit two prisons in each country (time constraints prevented researchers from visiting more prisons), prisons that differ in their geographical location, their type (remand, sentenced) and their approach and practise of substitution treatment. Two prisons were selected in each country and chosen further to discussion with and advise from national contacts. Researchers interviewed at each prison prisoners with a history of illegal drug use (any drugs, poly-drug use being frequent) and prison staff concerned with substitution treatment. All countries involved in the research were visited during the 18 months with the exception of Luxembourg as explained above. Details on the visit are contained within the final research report (Annex 28).

7. Monthly reports. A monthly report on progress of both research (STEP and CEENDSP) was written at the end of each month and sent to the scientific-peer reviewers, and to colleagues at Cranstoun Drug Services offices in Wimbledon (England), Brussels and Warsaw. This increased team communications, improved information sharing between colleagues and transparency about the work done.

8. Participation at conferences. In September 2003 the first CEENDSP (Central and Eastern European Network of Drug Services in Prisons) was held in Popowo (Poland) from 18 to 20 September. A workshop on substitution treatment in prisons was held where guest speakers presented substitution treatment in prisons in Belgium and in Poland. L. Hennebel introduced briefly the STEP research and Dr. Stöver presented the literature review on substitution treatment in prisons. Also the network conference in Prague was used to present the preliminary findings of the research and to gather advice from international experts in the field. Alongside with a plenary session a specific round-table on substitution treatment was organised. Please, see point 7 & Annex 27). Additionally to the network’s event, the study was promoted during international and national event where Network staff took part. Please see Point 1 for a detailed list of events.

24

4. RESEARCH METHODOLOGY

The research involved two phases: A. Collection of national data (general – on the community level – and

penitentiary) through the national contacts. B. Qualitative study conducted through field visits, organised with the

support of the national contacts.

This research was thus set on a double approach: (i) it examined the general situation of each country (legislations, protocols, agreements, procedure of substitution treatments, differences between substitution treatments offered in the community and those in prisons, etc.); and (ii) it investigated the specific situation of two penitentiary institutions selected in each country.

For the phase I of the research (i.e., collection of national data), the following tools were used:

- Review of relevant literature; - Search of databases; - Obtaining formal data and statistical information (prisoners per

100.000, etc.), requested from Ministries of Justice (18+), Ministries of Health (18+) and experts;

- Co-operation with other European Networks working in the prison and drugs fields (in particular with the European Network for Hepatitis and HIV/AIDS Prevention in Prison, coordinated by the German research institute WIAD);

- Conducting semi-structured interviews with experts and ENDSP’s contact persons via telephone, email and face-to-face during international conferences and field visits.

For the phase II of the research (i.e., qualitative study), each researcher conducted a field visit in each country during which they carried out open-ended interviews and focus groups in two prisons in each country, as well as interviews with relevant staff in ministries, and with NGOs concerned with substitution treatment.

Two interview’s structures were drawn: one for the prisoners and one for the professionals. These ensured that the research methods meet the reliability, validity, replicablity and rigour criteria.

For the field visits, the following actors were interviewed:

- INTERVIEWS WITH EXTERNAL ACTORS 1. Interviews with ministries’ staff (concerned with substitution treatment

in prisons but also in the community to understand the link between the two fields) from the following departments:

- Ministry of Justice; - Ministry of Health (if applicable); - Ministry of Education (if applicable).

2. Experts on substitution treatment, especially in prisons;

25

3. Key national NGOs and those working with and within the 2 selected prisons;

Actors interviewed for approximately 30 minutes, on a one-to-one basis or in a group (to their preference and according to the situation).

- INTERVIEWS WITH PRISON STAFF AND PRISONERS • Selection of Prisons

- 2 prisons; - located in different areas (one in a big city and another in a

smaller city or town); - different types (for instance, one remand and the other for

convicted prisoners); - different in their approach to substitution treatment (that is, for

instance, one prison that offers substitution treatment, and the other that does not).

• Prison staff Individuals concerned with substitution treatment:

- Management team; - Trainers/ training team of prison staff; - Probation service / Through care service or aftercare liaison; - Judicial staff (judge of the application of the sentence); - Health care / Drug treatment team (doctor, psychiatrist,

psychologist, social worker, nurse, …); - Other.

Interviews conducted on a one-to-one basis or in a group, depending on the staff’s preference and possibilities (time-table and work requirements) for approximately 30 minutes.

Anonymity and confidentiality were guaranteed at all stages of the research.

• Prisoners - Adult prisoners. Mainly male. A small group of female prisoners

(depending on the type of selected prisons); - Prisoners (a minimum of 6 prisoners and a maximum of 8 in each

prison) took part in focus groups (i.e. group interview with the researcher) in the sole presence of the researcher (and interpreter where applicable). The focus group usually lasted for up to 90 minutes;

- If permitted, the researcher used a tape-recorder (only if prisoners agreed to it). This was only to be used and listened to by the researcher and was to facilitate her/his work methodology (allowing them to concentrate on managing the focus group and not taking notes while interviewing);

- Prisoners were guaranteed (i) confidentiality and anonymity, that (ii) their participation was voluntary, and that (iii) they were allowed to withdraw from the group at any time.

26

5. COOPERATION WITH CEENDSP RESEARCH

The STEP research had closely been working with another research on the ‘Provision of Services to Drug Users in Prisons’ (one of the CEENDSP’s activity, please see Annex 1 of the first interim report) carried out by Dr. Morag MacDonald (University of Central England, Birmingham) in the 10 Central and Eastern European Countries. As well as general cooperation and exchange of information on drug services in prisons, a close collaboration between the two research projects was developed with regards to the three countries that both research shared, i.e. Poland, Slovenia and the Czech Republic.

STEP researchers have been conducting the field visit in these three common countries on STEP but also on ‘Provision of Drug Services in Prisons’ on behalf of Dr. MacDonald, using the list of open-ended questions for STEP and for MacDonald’s research.

6. SCIENTIFIC ADVISORY GROUP (SAG)

The scientific advisory group for STEP was set up as an important prerequisite for the success and scientific quality of the whole study. The SAG was composed by:

Professor Joris Casselman appointed as the scientific peer-reviewer and general advisor for the study (as mentioned above). Several meetings in Brussels and London took place to discuss the research design and methodology. He also served as Chair of the SAG.

Roy Walmsley, from the “International Centre for Prison Studies”, of King’s College London (UK), was appointed as the scientific peer-reviewer and general advisor for the CEENDSP’s research on ‘Provision of Drug Services in Prisons’ conducted by Dr. MacDonald.

Meetings with Professor Casselman and Mr Walmsley were regularly held with the three researchers (Hennebel, Stöver and MacDonald) to discuss the researches’ progress and scientific validity.

The following meetings were held: - 14 January, Brussels, Laetitia Hennebel (LH), Joris Casselman (JC),

Heino Stover (HS); - 21 January, Wimbledon, LH, JC, HS, MMD, ES; - 31 January, Wimbledon, LH, Morag Mac Donald (MMD), Vikky Bullock

(VB), Grzegorz Krol (GK – CEENDSP), Magdalena Ruszkowska (MR – CEENDSP), Terhi Viljanen (TV – HEUNI), Edoardo Spacca (ES);

- 13 February, Brussels, LH, JC, HS, MMD; - 24 March, London, MMD, LH; - 29 April, London, MMD, LH, HS; - 30 April, London, LH, HS; - 24 May, Rome, LH, HS, JC, MMD; - 3 June, Wimbledon, LH, HS, JC, MMD, Roy Walmsley, ES;

27

- 17 September, Popowo (Warsaw), SAG meeting, LH, HS, JC, RW, MMD;

- 18 Sept., Popowo (Warsaw), STEP meeting, LH, JC, HS. - 3 December, Brussels, STEP meeting, LH, JC, HS. - 2004 - 3 Feb, Brussels, STEP meeting, LH, HS, JC, ES; - 11 Feb, London, SAG meeting, LH, HS, MMD, RW, ES; - 25-27 March, Prague (during the conference), SAG & STEP meetings,

LH, HS, JC, MMD, RW, TV, GK, MR, ES; - 2 May, Brussels, STEP meeting JC, LH, HS.

Two further experts in the field of substitution treatment in prisons were part of the SAG, as scientific advisors. They did not however take part in any meetings but were consulted.

Dr. Karlheinz Keppler medical doctor in the Women’s prison of Vechta in Lower-Saxony (Germany) acted as medical advisor for all relevant questions of medical details on substitution treatment.

Professor Dr. Johannes Feest, criminologist from the University of Bremen and director of the “Archive for Penal Studies in Bremen, Germany”, provided support by making contacts and delivering relevant literature for the research.

13) Involve self-help organisations and user groups in the activities

of the Network, providing a forum for discussion between those who provide prison drug services and those who use them. A special forum on self-help organisations and peer support will be included in the Prague conference in April 2004. In addition, a specific seminar on “User groups and self-help organisations entering the prisons” will be organised in Brussels in December 2002. The seminar will involve 60 to 80 participants, and it will seek to identify the barriers to the provision of drug services in prisons by user groups and self/help organisations and look at practical ways to address and overcome these. (The preparatory work in order to involve prison administrations, users organisations and self-help groups in UK and Europe has already been started by Cranstoun Drug Services outside the scope of the activities of the Network).

The Brussels Seminar has been successfully held on the 13-15 February 2003, being the initial dates for this event rescheduled to have more time to prepare it. The event itself was preceded by the Steering Group Meeting of both ENDSP and CEENDSP, on the 12th of February. The Seminar was organised in Brussels, at the management Centre Europe. 105 delegates participated representing both statutory and non-statutory organisations, from 27 countries. Simultaneous interpretation was provided for in English, French, and Russian.

28

We were successful in involving in the scientific organisation of the event both NGOs, International Organisations and European Networks. The following took part in the scientific organising committee:

- European Network on HIV and Hepatitis Prevention in Prison; - AC Company – European Network for the target Group of Mobile Drug

Users; - WHO/OMS – Health in Prison Project; - Pompidou Group – Council of Europe; - Belgian Ministry of Justice;

A list of participants, along with the Seminar reader and materials were enclosed to the first interim report as Annex 6). Contents of the Seminar The Seminar was chaired by Sir Richard Tilt, former Director General of the English and Welsh Prison Service, until 1997 during which time he played an important role in the setting up of one of the most successful peer support schemes in the UK, The Listeners Scheme�, aimed at providing support to prisoners in danger of self harm. The conference opened with a debate, conducted by a panel consisting of: Dr Manuela Santos Pardal, a Portuguese public health doctor specialising in AIDS prevention in prison and member of the consultant board of the Portuguese National AIDS Commission; Franz Trautman, Head of International Affairs at the Trimbos Institute, Holland; Dennis Jensen, vice-president of, the Danish Drug Users Union; Jorgen Jepsen, Professor of Criminology at the University of Arhus Denmark and cofounder of the Danish Centre for Alcohol and Drug Research; and Dr Alexander Kononetz, Director of Health for the Russian Prison Administration. The debate highlighted important issues concerning Peer support which provided a context and focus for the rest of the seminar. These included the definition of peer support, the difference between peer support and peer education, the question of remuneration for prisoners working as peer supporters, working with external user groups, existing barriers to peer support as well as the issue of training. The opening day concluded with a networking and poster session, allowing delegates to continue discussions inspired by the debate and to network with colleagues in the field. The second day opened with a plenary session with presentations relating to Peer support, including an inspiring and insightful presentation given by Vitalik

� the Listeners scheme was set up by the Samaritans, a nationwide charity founded in the UK in 1953 to provide confidential around the clock support to anyone going through an emotional crisis, usually a suicidal one.

29

Melnikov, President of Kolodets, a Russian NGO from Moscow. Mr Melnikov’s presentation offered a comprehensive picture of issues currently affecting drug dependent individuals. One of the strongest messages conveyed by the presentation was the necessity to change not only society’s view of drug users but also drug users’ view of themselves and that in fact the two are interlinked. It was suggested that peer support can be used as a way to achieve this. Kathryn Leafe of Cranstoun Drug Services looked at the training implications of peer support, whilst Peter Soderlund and Christer Karlsson from CRIS Stockholm presented an abstinence based community peer support scheme for people with dependency issues leaving prison. Focusing on the issues related to engagement, Annie May West from Rugby House introduced the seminar to the work of New Roots, a London based project aimed at black and ethnic minorities with alcohol abuse issues. Her presentation stressed the positive effect of cultural sensitivity towards clients, particularly in relation to peer support schemes. Jol Van Lierde from the Belgian NGO Modus Vivendi presented the Snowball Operation, a peer support project where drug users and former drug users pass on risk reduction information and equipment to their peers, and the session ended with Kathy Biggar, from HM Prison Service’s Safer Custody Group explaining the work done to set up the Listeners Scheme in the UK and how experiences gained through establishing this successful scheme can be useful in the planning stages of any peer support scheme with prisoners. The presentations paved the way for the main event of the seminar and after lunch participants divided into four working groups to discuss various aspects raised by the presentations. The groups, each comprised of representatives from a cross-section of disciplines, approached the issues from four different perspectives: security; migrants; parallel experiences and training. Each group had a facilitator and rapporteur and was given the job of devising recommendations relating to their particular perspective and feeding back to the conference the following morning during the closing session. It was clear from the closing session that a great deal of discussion and input had occurred during the working sessions and a list of recommendations was established for each of the four areas discussed. These recommendations will be summarised in the conference report, which will be published before the end of the year. However, the main conclusion, endorsed by a show of hands in the final session, was that there is a vital need for research into the area of peer support. The aim behind this research being to promote development of this untapped resource and provide the necessary authorities with an evidence base regarding the possible role of peer support in the field of drug treatment and harm reduction in prisons. A research proposal was made by Morag MacDonald on the basis of the above conclusions of the Seminar (please, see Annex 6a of the first interim

30

report), and we are now actively searching for funding to implement and carry it out. Promotion and Organisation of the Event 5,000 copies of the leaflet (please, see Annex 7 of the first interim report), including call for abstracts, were distributed in December throughout Europe and beyond, both directly through our database, and indirectly through our National Contact Points and Coordinators, and through the scientific partners of the event. Logistic arrangements were confirmed at the very beginning of the project, in December 2002. Salma Master and Haley Fraser (respectively Manager of Cranstoun Independent Management, and administrative assistant) visited again the venues in January. The programme of the event was prepared in cooperation with the Scientific Partners. The Seminar report (Annex 25) was published in February 2004 in 500 copies. Vikky Bullock, ENDSP Officer coordinated the team of voluntary rapporteurs and chairs of the working-groups, and edited the material gathered. The report has been disseminated to all Brussels’ seminar participants, as well as to all delegates to the Prague conference, and is currently available online on the website of the Network. Finally, the conference operations and logistic were arranged through Cranstoun Independent Management, which was contracted to do so on 4th December 2002 (please, see Annex 8 of the first interim report, contract with Cranstoun Independent Management). Additionally to the event in question, Cranstoun and the Network have been involving representatives of user unions in other events, such as the Prague conference (Job Joris Arnold, Director of MGDH – Amsterdam Drug User, NL, and Theo Van Dam, Director LSD, NL) and the 3rd British Community & Residential Drug Workers Conference in Glasgow, May 2004 (again Job Joris Arnold & Vitaly Melnikov, from Kolodetz / New Drug Policy Alliance, Moscow). See also Point 8.

14) Co-operate with the European Network for HIVAIDS and Hepatitis C Prevention in Prison in gathering and disseminating information throughout the European Union. This Network will be offered a session at the Prague Conference.

Cooperation with the Network coordinated by the German Institute WIAD has gone extremely far, and Edoardo Spacca and Caren Weilandt have been cooperating throughout the implementation of the project. Dr Weilandt, coordinator of the ENHHPP, has been one of chairs of the Brussels Working Seminar, as well as of the Prague Conference.

31

Further to this, and far more relevant, Cranstoun and WIAD decided to put resources together and to integrate the two Networks, along with the CEENDSP. This intention has been formulated to the EC in the form of a project proposal presented under the first call for proposals of the Framework Programme on Public Health. The New Network was called the ENDIPP or European Network on Drugs & Infections Prevention in Prison.

For the preparation of the proposal we involved 65 organisations, representing partners from 27 countries and observers from other 5 European and extra-European Countries (Ukraine, Russia, Iran, Thailand and Switzerland), as well as WHO-Europe and Pompidou Group (Council of Europe) as partners, UNODC as observer, and the EMCDDA as supporter. The proposal prepared jointly by WIAD & Cranstoun has been approved by the EC for funding (information was received by WIAD in August 2004), and Edoardo Spacca and Caren Weilandt met again in October in Bonn (please, see above Point 1) to define the details of each organisation financial involvement in the operation. The meeting was necessary because the EC did approve the proposal, but offered a reduced co-funding with respect to what was asked in the proposal. Caren Weilandt & Edoardo Spacca also arranged a meeting in Wimbledon, on 19-20 January 2004 to discuss the beginning of the project implementation. All Cranstoun staff involved with the network participated to the meeting, and roles and responsibility for the various offices were discussed in details, as well as the members of the steering groups of the new network were established.

15) Offer support to any organisation that seeks to develop

transnational European projects on the prevention of drug dependence in prison. This will be done by providing information and useful contacts to such projects and, if appropriate, by integrating their activities into those of the Network (e.g. by offering them space at the Prague Conference to meet their contacts and to present their activities).

That has been done with Sdruzeni Podane Ruce and Sananim, Czech Republic, for the presentation of both PHARE proposals and within the frame of the new Public Health Framework Programme, and with Dario Foa, for the presentation of a proposal on alternatives to imprisonment within the AGIS programme, managed by DG JHA, as well as under the provision of training in Czech Republic and Bulgaria, where Better Mental Health Foundation and other organisations are given full assistance on matters related to fund rising. As far as events are concerned, both Seminars in Brussels and Rome have been occasion for organisations from the EU, CEEC, and NIS to disseminate information on their transnational activities. Please, see points 10 and 13.

32

Edoardo Spacca met Eberhard Schatz (ACCompany) and Jon Peter Kools (Mainline, NL) on 15 December 2003 to provide support & advice to develop a proposal to be presented for the next call for proposal under the Public Health Framework Programme. In the proposal Cranstoun & ENDSP have been nominated part of the advisory group to the project. The Prague Conference was used in the same way as the other two events organised by the ENDSP in the first part of 2003. In particular, ACCompany and the Secretariado Gitano were offered space at the conference to disseminate materials and network with colleagues. The Segretariado Gitano withdraw at the last moment from the event.

16) Publish (November 2003) the 6th updated edition of the Digest of

International Research on Drugs and HIV in Prisons.

This target was over-achieved, for the digest has been updated twice during the implementation of this project. Mr Artur Krol, who already served as intern for Cranstoun and the Network during the summer of 2002, repeated the experience during summer 2003 and the New edition of the Digest was published in August 2003 (Annex 14), and disseminated in September 2003 during the Warsaw Conference (please, see Annex 1 of the 1st Interim Report), as well as during the Prague Conference. In February 2004 a new intern started in Cranstoun EU Liaison Office in Brussels, Ms Jana Arskovska from Macedonia. She updated the digest producing the 7th Edition which was published in May 2004. Please find the electronic version of the digest in Annexe 22. The Digest is currently available online at the Network’s website.

17) Hold one meeting of the Network Steering Group. This group will

be made up of eight of the Network’s National Coordinators. It will evaluate the work of the Network and decide how best to achieve its aims in future. This meeting will be held in London in February 2003.

The Steering Group meeting was organised in Brussels, 12 February 2003, on the eve of the European Seminar on Peer Support (please, see point 13), jointly with the CEENDSP SG, which met on the same day in the same place. The following individuals took part to the meeting:

- Edoardo Spacca – ENDSP Coordinator; - Laetitia Hennebel – ENDSP Researcher; - Vikky Bullock – ENDSP Officer;

33

- Tore Rokkan – Tyrili Research and Development – ENDSP Contact Point in Norway;

- James Eagan – Scottish Drugs Forum, ENDSP Contact Point in Scotland;

- Heino Stover – University of Bremen, ENDSP SAG (Research) Member;

- Jesus Trujillo – La Montaneta Young Offenders Institution, Gran Canaria, ENDSP Coordinator for Spain;

- Walter Kahl – Ministry of Justice, ENDSP Contact Point Austria; - Dario Foa – Milan Health Authority, ENDSP Coordinator in Lombardia,

Italy; - Marketta Jungner – Criminal Sanctions Agency, ENDSP Coordinator

for Finland; - Susana Falchini – Florence Health Authority, ENDSP Coordinator in

Tuscany, Italy; - Irene Puppo – Florence Health Authority, Italy; - Steve Rossell – Chief Executive – Cranstoun Drug Services, UK; - Alfred Steinacher – Governor of Hirtenberg Prison, Ministry of Justice,

ENDSP Coordinator Austria; - Joris Casselman – Catholic University of Leuven, ENDSP SAG Chair

Belgium; - Willy De Maere – Free Clinic v.z.w, ENDSP Coordinator for Belgium; - Jan Fikkema – Ministry of Justice, Netherlands; - Michel Amoreus - Ministry of Justice, Netherlands; - Petra Paula Merino – Project Manager, EMCDDA; - Vanessa Fowler – Research Consultant, UK.

The meeting discussed present and future activities of the network, with a particular focus on the Research Project and the Events. For more details on the meeting, please see the minutes, Annex 9 of the first interim report.

18) Facilitate Work Exchanges for professionals from the EU and

CEECs. 12 professionals will be offered the opportunities to spend two weeks in a prison-based project of their choice in a EU country with the aim of learning new practices to bring back to their country.

This target has been achieved through a number of study visits organised by Cranstoun for professionals from CEECs.. Visits were requested from professionals from Bulgaria, Slovenia, Poland Czech Republic, Slovakia, Lithuania, and Hungary. Because of the engaging work plan of the Netaork, visits mostly took place in the last semester of the project. The Scottish Prison Service also offered its full support and availability to facilitate and acknowledge the visits. A study visit from Czech Republic, coordinated with Sdruzeni Podane Ruce (that provided funding for the visit), was hosted on 14-17 April 2003 in London. Participants included members of the Probation Service and the

34

Ministry of Justice. They were familiarised with the English system, both through presentations and on-site visits to a number of services in London metropolitan area. From the 27 October to 5th November 2003 a study visit was organised for Ivan Popov and Radoslav Zlatkov, of Better Mental Health Foundation, Varna, Bulgaria. They were taken to a number of services managed by Cranstoun, including prison projects, community drug agencies & therapeutic communities. They were also invited to participate to the Conference Cranstoun has organised in the UK on Crack-Cocaine, which was held in Oxford on the 3rd & 4th of November. Paddy Costall and Vikky Bullock hosted a study visit for Marek Szostek – Deputy Director of Polish Prison Service – responsible for Probation, Andrzej Martuszewicz - President of the Polish Association of Probation Officers, and col. Adam Laptas - Regional Director of PS – Silesia. The visit was arranged in cooperation with the National Association of Probation Officers in the UK and took place from 10th May 2004 and 14th May 2004. The visitors were familiarised with the English probation system, both through presentations and on-site visits to a number of probation facilities in London metropolitan area. Edoardo Spacca, Vikky Bullock and Paddy Costall hosted a study visit for 4 professionals from Central and Eastern Europe between 24th and 28th May. The professionals invited were Dusan Valentincic, Director General of the Slovenian Prison Service, Olga Perhavc, Head of Drug Treatment at the Slovenian Prison Service, Laszlo Huszar, Deputy-Director General of the Hungarian Prison Service, Ruminta Stuykite, Director of the Central and Eastern European Harm Reduction Network, and Katarina Jiresova, Director of ODYSSEUS, Slovak NGO. Dr Perhavc had unfortunately to withdraw from the visit at the very last minute for the sudden loss of her mother. During the programme of the visit participants were shown and had the opportunity to meet managers, workers, and clients of a number of residential and day centres for drug dependent individuals as well as seeing how different parts of the English criminal justice system work. They visited the prisons of Belmarsh (maximum security establishment) and Brixton (medium security) in London. The visit has also been the occasion for starting planning the next 2 European Conference of the Network, which will take place in Budapest and in Lubljiana respectively in 2005 and 2006. Vitaly Melnikov, from the Russian New Drug Policy Alliance, was invited to the UK to speak at the 3rd UK Community and Residential Services Conference held in Glasgow from 17th – 19th May 2004, and to visit organisations involved in drug policy in England and Scotland. Organisations visited included the Scottish Drug Forum, in Glasgow, and community services in London managed by Cranstoun Drug Services (The Base, and Greenwich & Bexley). Edoardo Spacca met Parviz Afshar, Director of Health Care for the Iranian Prison Service, during his visit to UK, on 21-26 of July 2003. During the visit it was discussed ways & forms of cooperation between the Iranian Prison

35

Service & ENDSP and Dr Afshar was accompanied to visit Brixton and Hollway Prisons in London. Vikky Bullock met Ms Ene Orumaa in London on the 8th of August 2003. Ms Orumaa is Project Co-ordinator for the National Programme for Alcohol and Drug Prevention in Estonia. She presented the activities of Cranstoun & the ENDSP to the visitor, who was in London within the frame of the Pompidou Group Fellowship, and she hosted a visit to two services managed by Cranstoun, “Oak Lodge”, TC in Putney, and “The Base”, Community Drug Agency in Wimbledon. Additionally to colleagues from CEECs and NIS, Cranstoun has also been involved in study visits organised by the Foreign and Commonwealth Office, and in particular: Peter O’Loughlin hosted a visit to Belmarsh Prison London for 8 members of the Iranian administration, including representative of the Drug Control Headquarters in Theran, on Wednesday 12th May. The visit took place in the context of a programme organised by the UK Home Office to familiarise the delegation with the way that the criminal justice system in England and Wales deals with drug related crime. Paddy Costal, Vikky Bullock and Peter O’Loughlin on the 19th of March 2004 hosted an informal meeting in London with a high level delegation from Central Asian Countries as part of a study visit organised by the Foreign and Commonwealth Office on Prison & Prison Reform.

19) Maintain contact with other Networks, such as PREVNET,

SASTIPEN, T3E, FESU, GEERM, and TIMC so that professionals working in prisons can benefit from developments in the fields covered by these Networks (and by other Networks in related fields of activities) and in order to avoid overlapping in the respective activities.

Cooperation and Contacts are maintained with a number of European Networks, in particular those supported by the EC. Regular exchange of information and news happens with Eberhard Schatz, Coordinator of AC-Company, the European network for the Target Group of Mobile Drug Users, and with Mark Frame at the Secretariado Gitano (Sastipen) – Spain. Additionally, AC-Company and the European Network for HIV and Hepatitis Prevention in Prison have participated in the scientific organisation of the Brussels Seminar. Also Michel Marcus of FESU is regularly kept informed of the activities of ENDSP, and Jana Arsovska took part, as representative of ENDSP, to the meeting organised in Paris on the 26 of March 2004 to plan a common

36

proposal for the new call under the Publich Health Framework Programme. Cranstoun decided then not to take part to this proposal. Finally, during both the Brussels and Rome Seminar we continued the dissemination of the WHO/Pompidou Group Consensus Statement on Prisons, Drugs and Society, already initiated last year. Please, see points above on the organisation of the Prague Conference. In general contacts are maintained and information is exchanged on current and future activities with SASTIEPEN, ACCompany, FESU, and in particular with WHO-HiPP & Pompidou Group. Also links have been developed with Raminta Stuikyte, Director of the Central & Eastern European Harm Reduction Network, based in Vilnius, Lithuania.

20) Maintain our Internet web site in order to further improve

dissemination of information and distribution of our publications. It will contain a classified electronic mailing list of all our contacts plus links to other relevant sites, and the possibility of registering on-line in order to receive notice of the activities of ENDSP.

Work is ongoing for this target, and the site appears now also on the one of the organization www.cranstoun.org . A web-site has been realized for the Central and Eastern European Network of Drug Services in Prison too, www.ceendsp.net . Plans were made to merge the ENDSP & the CEENDSP websites, and they have been integrated under the new www.endipp.net Personnel Vikky Bullock, British National who speaks fluently Spanish and French, had been acting ENDSP Officer during Sue Tracey maternity leave, which lasted until May 2003. In May 2003 Mrs Tracey decided to move to another position within the Organisation, and Ms Bullock took permanently office as Network Officer. Ms Bullock was promoted Service Manager in January 2004. Internships: Artur Krol, Polish national who speaks English, Russian and Polish served as Intern at Cranstoun Central Office in London during June-September 2003. he has been working for 3 months (13 weeks) as volunteer for 4 days a week for a total of 52 working days during the implementation of the project. Jana Arsovska, Macedonian national who speaks English, French, Greek, Serbo-Croat, and Bulgarian served as Intern at Cranstoun EU Liaison Office between February and June 2004. She has been working as volunteer from

37

last week in February to first week in June, for 4 days a weekm for a total of 53 days working days during the implementation of the project. Both interns’ work has been accounted for in the budget under Contribution in kind. Please see for more details the narrative enclosed with the financial report. New Brussels Office To face the dramatic increase in the constituency of the Network, as well as to be closer to the Institution and act more effectively in the promotion of drug prevention & treatment policies in prison at the political level Cranstoun opened its EU Liaison Office in Brussels on February 2004. The office is meant to act as coordination structure for the activities of the Network, as well as a central point for advocacy for partners & members of the Network. Edoardo Spacca (Area Manager for Europe) & Laetitia Hennebel (European Research Officer) were seconded to the Brussels office. Finance Please, see the enclosed narrative to the Final Financial Report.

List of Annexes NB: Annex 1 to 9 have been enclosed with the First Interim Report @ 3.06.2003. Annex 10 to 16 were enclosed with the 2nd Interim Report @ 3.12.2003. Additional copies of the above annexes are available upon request. Annex 1 List of partners, activities, research and events for the Central

and Eastern European Network of Drug Services in Prison (as stated in the application for funding approved by the EC)

Annex 2 Rome Seminar, 3 copies of list of participants, reader &

materials Annex 3 Rome Seminar leaflet, 3 copies Annex 4 Rome Seminar, contract with Cranstoun Independent

Management Annex 5 Minutes of the meetings of the Scientific Advisory Group

38

Annex 6 Brussels Seminar, 3 copies of list of participants, reader and material

Annex 6a Research Proposal from the Conclusion of the Brussels Seminar Annex 7 Brussels leaflet, 3 copies Annex 8 Brussels Seminar, contract with Cranstoun Independent

Management). Annex 9 ENDSP Steering Group minutes Annex 10 Issue No 13 of Connections. 3 copies of each linguistic version. Annex 11 List of Articles for Connections, Issue No14. Annex 12 3 copies of the Prague Conference Leaflet. Annex 13 3 copies of the Conference Materials from the 11th British Prison

Drug Workers Conference, held in Nottingham. Annex 14 6th edition of the Digest of International Research on Drugs &

HIV/AIDS Services in Prison. Annex 15 List of partners of the WHO-HiPP http://www.hipp-

europe.org/contacts/partners/default.htm Annex 16 3 copies of the Materials of Oxford Conference on Crack

Cocaine Annexes (3 copies each) added to the Final Report Annexe 17 Community & Residential Conference Materials Annexe 18 Programmes of study visits Annexe 19 Prague conference materials Annexe 20 Connections 14 Annexe 21 Connections 15 Annexe 22 7th edition of the Digest Annexe 23 Minutes and attendence record of Prague steering group

39

Annexe 24 Contracts with CIM for Prague Conference Annexe 25 Brussels Seminar Report Annexe 26 Rome Seminar Report Annexe 27 Prague Conference Report Annexe 28 STEP Research report Annexe 29 Paolo Pertica Felloship – Call for Applications

This report was produced by a contractor for Health & Consumer Protection Directorate General and represents the views of thecontractor or author. These views have not been adopted or in any way approved by the Commission and do not necessarilyrepresent the view of the Commission or the Directorate General for Health and Consumer Protection. The EuropeanCommission does not guarantee the accuracy of the data included in this study, nor does it accept responsibility for any use madethereof.